Caring Brands (NASDAQ:CABR) Issues Earnings Results

Posted by Teresa Graham on Apr 1st, 2026

Caring Brands (NASDAQ:CABR – Get Free Report) released its earnings results on Tuesday. The company reported ($0.29) EPS for the quarter, Zacks reports.

Caring Brands Stock Down 1.3%

Shares of CABR traded down $0.02 on Wednesday, hitting $1.13. 2,596 shares of the stock traded hands, compared to its average volume of 150,712. Caring Brands has a one year low of $0.71 and a one year high of $5.35. The firm has a 50 day simple moving average of $0.90.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings initiated coverage on Caring Brands in a research report on Monday, January 26th. They issued a “sell (e)” rating for the company. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

View Our Latest Stock Report on CABR

Institutional Trading of Caring Brands

A hedge fund recently bought a new stake in Caring Brands stock. Jane Street Group LLC acquired a new stake in shares of Caring Brands, Inc. (NASDAQ:CABR – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 34,446 shares of the company’s stock, valued at approximately $30,000. Jane Street Group LLC owned about 0.25% of Caring Brands as of its most recent SEC filing.

Caring Brands Company Profile

(Get Free Report)

We are a wellness consumer products company. We offer several over-the-counter, or (OTC) and cosmetic, consumer products. Our method of operation is to ensure that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability. Prior to its Q3 2022 commercial launch in India as a treatment for vitiligo and psoriasis, Photocil was briefly launched in the United States markets from December 2022 until February 2023, however, was subsequently removed from the market due to insufficient sales resulting from the lack of a dedicated sales and marketing team.